drugset / Trial / NCT01808768
Ocular Allergy Treatment Practical Impact Trial
NaSingle-groupOpen-labelTreatment
Summary
To study the impact of alcaftadine in patients treated with other opthalmic ocular agents (or specific topical opthalmic treatment) in an allergy subspecialist outpatient setting.
Timeline
- Start
- 2013-04
- Primary completion
- 2013-10
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alcaftadine | Small molecule | 0.25 % | Other |